Na Tosha N. Gatson, MD, PhD
Professor of Neurology
Adjunct Professor of Medicine
Bio
Na Tosha N. Gatson, MD, PhD, FAAN, joined Indiana University School of Medicine faculty as a professor of neurology in March 2024. Dr. Gatson is also the senior medical director of neuro-oncology and director of the Center for Neuro-oncology in the IU School of Medicine-IU Health Neuroscience Institute.
Dr. Gatson completed undergraduate studies at Indiana University Purdue University-Fort Wayne before spending the next 15 years training at The Ohio State University College of Medicine, completing an MD/PhD (MSTP) degree in molecular virology, immunology and medical genetics with a major emphasis on neuroimmunology. She also completed an internal medicine internship, a neurology residency, and an enfolded NIH/R25 neurosurgical oncology postdoctoral research fellowship. Dr. Gatson studied as a neuro-oncology fellow at the University of Texas MD Anderson Cancer Center in Houston, TX.
Dr. Gatson’s practice philosophy is rooted in compassionate and evidence-based care that extends a quality life. Her research is focused on population science, brain tumor imaging, and the Neuro-Oncology of Women (N.O.W.).
Dr. Gatson enjoys meditating, spending time with family, creative writing, weightlifting, kickboxing, mentoring and traveling.
Year | Degree | Institution |
---|---|---|
2016 | Fellowship | University of Texas M D Anderson Cancer Center |
2014 | Residency | Ohio State University Hospital Program |
2013 | Postdoctoral Training | Ohio State University Hospital Program |
2009 | MD | The Ohio State University |
2007 | PhD | The Ohio State University |
1999 | BA | Indiana University-Purdue University Fort Wayne |
Brain Tumor Clinical Trials
Brain Tumor Imaging
The Neuro-Oncology of Women (N.O.W.)
Population Science & Vulnerable Populations
Neuro-Oncology. Treating brain, spinal cord, and neuronal tumors
Primary – Gliomas (Astrocytoma, Ependymoma, Oligodendroglioma), Medulloblastoma,
Schwannoma and Malignant Nerve Sheath Tumors, Meningioma, CNS Lymphoma,
Hemangiopericytoma, Ganglioglioma, and a host of other rare intracranial tumors in adults
Metastatic (Secondary) – Lung, Breast, Melanoma (skin), Colon/Gastrointestinal, Kidney,
Thyroid, Genitourinary, Gynecologic, and other rare secondary cancers including
Leptomeningeal Metastases [LM]/Leptomeningeal Carcinomatosis [LMC] spread into the
cerebrospinal fluid around the brain and spinal cord.
Cancer Neurology. Treating neurological complications of cancer or cancer treatment
Neurologic injury by cancer cell invasion or neurologic complications of chemotherapy,
immunotherapy, targeted therapy, surgery or radiation, including: neuropathy, seizure,
cognitive/memory changes, fatigue, weakness, gait instability, headache, radiation necrosis,
myelopathy, tremor, language or speech deficits, sexual dysfunction, spasms, vision or
hearing loss, insomnia, mood or behavioral changes, and a host of other neurologic
conditions that are potentially linked to cancer.